GSK Investigational Site

Jingzhou 434020

0 studies enrolling now · 2 studies all time

What they study most

Cough, Nasal Polyps, Refractory Chronic Cough

Studies at this site

• A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough — Running, not enrolling
• Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps — Completed